Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Bibliographic Details
Main Authors: Amanda L. Piquet, John R. Corboy, Timothy L. Vollmer
Format: Article
Language:English
Published: SAGE Publishing 2021-05-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864211019567
id doaj-a3d14c63e72c40679d8c5240d1b73653
record_format Article
spelling doaj-a3d14c63e72c40679d8c5240d1b736532021-05-31T22:04:07ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28642021-05-011410.1177/17562864211019567Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAmanda L. PiquetJohn R. CorboyTimothy L. Vollmerhttps://doi.org/10.1177/17562864211019567
collection DOAJ
language English
format Article
sources DOAJ
author Amanda L. Piquet
John R. Corboy
Timothy L. Vollmer
spellingShingle Amanda L. Piquet
John R. Corboy
Timothy L. Vollmer
Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Therapeutic Advances in Neurological Disorders
author_facet Amanda L. Piquet
John R. Corboy
Timothy L. Vollmer
author_sort Amanda L. Piquet
title Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
title_short Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
title_full Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
title_fullStr Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
title_full_unstemmed Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
title_sort correspondence to: humoral immune response to covid-19 mrna vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
publisher SAGE Publishing
series Therapeutic Advances in Neurological Disorders
issn 1756-2864
publishDate 2021-05-01
url https://doi.org/10.1177/17562864211019567
work_keys_str_mv AT amandalpiquet correspondencetohumoralimmuneresponsetocovid19mrnavaccineinpatientswithmultiplesclerosistreatedwithhighefficacydiseasemodifyingtherapies
AT johnrcorboy correspondencetohumoralimmuneresponsetocovid19mrnavaccineinpatientswithmultiplesclerosistreatedwithhighefficacydiseasemodifyingtherapies
AT timothylvollmer correspondencetohumoralimmuneresponsetocovid19mrnavaccineinpatientswithmultiplesclerosistreatedwithhighefficacydiseasemodifyingtherapies
_version_ 1721418752737673216

Similar Items